Randomised clinical trial: a dose‐ranging study of vonoprazan, a novel potassium‐competitive acid blocker, vs. lansoprazole for the treatment of erosive oesophagitis

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 6, 2015-09 ,pp. : 685-695

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacokinetics, pharmacodynamics, safety, and tolerability of pradigastat, a novel diacylglycerol acyltransferase 1 inhibitor in overweight or obese, but otherwise healthy human subjects

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 9, 2015-09 ,pp. : 1031-1041

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacokinetics and Pharmacodynamics of Anacetrapib Following Single Doses in Healthy, Young Japanese and White Male Subjects

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 58, Iss. 2, 2018-02 ,pp. : 254-262

John Wiley & Sons Inc

Access to resources Recommend Favorite

A novel CRTH2 antagonist: Single‐ and multiple‐dose tolerability, pharmacokinetics, and pharmacodynamics of ACT‐453859 in healthy subjects

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 7, 2015-07 ,pp. : 787-797

John Wiley & Sons Inc

Access to resources Recommend Favorite

Safety, tolerability and pharmacokinetics of escalating doses of NXY-059 in healthy young and elderly subjects

By Wemer Johan   Cheng Yi-Fang   Nilsson Dag   Reinholdsson Ingalill   Fransson Bo   Lanbeck Vallén Kerstin   Nyman Lars   Eriksson Catarina   Björck Staffan   Schulman Sam  

Current Medical Research and Opinion, Vol. 22, Iss. 9, 2006-09 ,pp. : 1813-1823

Informa Healthcare

Access to resources Recommend Favorite